Avantex Biotechnologies Inc.
  • About
    • Overview
    • Management & Directors
    • Disclaimer
  • Applications
    • Eye-Care Application
    • Lung Cancer Application
    • – Lung Cancer Problem
    • – Lung Cancer in China
    • Cannabis Applications
    • MRI Application
    • Published Research Papers
  • News
    • Industry News
    • Media Contact
  • Contact
    • Contact Information
  • Menu Menu

News

Industry News

Avantex Biotechnologies Inc. provides industry news relevant to our medical cannabis and other therapies sectors.

What to Expect From the Launch of Cannabis Edibles in Canada

December 31, 2019/in In the News/by avantexb

Published on Pot Stock News – By Caileam Raleigh  • Dec 31, 2019  With January 1 comes the arrival of a new year, and a new decade, and it promises to be a watershed moment for the Canadian cannabis market. 2020 will see the long-awaited arrival of legal cannabis edibles and other ingestible forms of marijuana, products that […]

Read more
http://avantexbio.com/wp-content/uploads/2017/05/avantext-bio-logo-Active-targeting-nano-particle-dual-drug-co-delivery-system-synergistic-anti-cancer-therapy-improved-cancer-therapeutics-2.png 0 0 avantexb http://avantexbio.com/wp-content/uploads/2017/05/avantext-bio-logo-Active-targeting-nano-particle-dual-drug-co-delivery-system-synergistic-anti-cancer-therapy-improved-cancer-therapeutics-2.png avantexb2019-12-31 12:00:502021-10-11 23:50:28What to Expect From the Launch of Cannabis Edibles in Canada

New Cannabis Products to Follow Edibles Legalization

September 5, 2019/in In the News/by avantexb

Published by Market Realist • By Sharon Bailey • September 5, 2019  The second wave of cannabis legalization in Canada will allow the sale of edibles, beverages, extracts, and topicals effective October 17. The new products should hit the stores in mid-December, as federal license holders must give a 60-day notice to Health Canada regarding their plans to […]

Read more
http://avantexbio.com/wp-content/uploads/2017/05/avantext-bio-logo-Active-targeting-nano-particle-dual-drug-co-delivery-system-synergistic-anti-cancer-therapy-improved-cancer-therapeutics-2.png 0 0 avantexb http://avantexbio.com/wp-content/uploads/2017/05/avantext-bio-logo-Active-targeting-nano-particle-dual-drug-co-delivery-system-synergistic-anti-cancer-therapy-improved-cancer-therapeutics-2.png avantexb2019-09-05 12:00:202021-10-11 23:51:08New Cannabis Products to Follow Edibles Legalization

Canada’s cannabis edibles, topicals market could be worth $2.7B a year after legalization: study

June 3, 2019/in In the News/by avantexb

Published by Global News – By JON AZPIRI  Posted June 3, 2019 The market for cannabis edibles could be worth roughly $2.7 billion a year, according to a new report. A study by Deloitte found the next phase of cannabis legalization — which will include edibles other alternative cannabis products — could generate higher profits for retailers. […]

Read more
http://avantexbio.com/wp-content/uploads/2017/05/avantext-bio-logo-Active-targeting-nano-particle-dual-drug-co-delivery-system-synergistic-anti-cancer-therapy-improved-cancer-therapeutics-2.png 0 0 avantexb http://avantexbio.com/wp-content/uploads/2017/05/avantext-bio-logo-Active-targeting-nano-particle-dual-drug-co-delivery-system-synergistic-anti-cancer-therapy-improved-cancer-therapeutics-2.png avantexb2019-06-03 12:00:232021-10-11 23:51:44Canada’s cannabis edibles, topicals market could be worth $2.7B a year after legalization: study

Scientists Are Racing to Make Weed As Easy to Drink as Beer

March 26, 2019/in In the News/by avantexb

The challenge is to create marijuana beverages that hit at the same time as alcoholic ones. By Kristine Owram • February 6, 2019, 2:00 AM PST People who drink alcohol typically learn the hard way how much is too much—usually in their teens or early 20s. As adults, they’re not interested in learning the same hard-knocks lesson about cannabis. This […]

Read more
http://avantexbio.com/wp-content/uploads/2017/05/avantext-bio-logo-Active-targeting-nano-particle-dual-drug-co-delivery-system-synergistic-anti-cancer-therapy-improved-cancer-therapeutics-2.png 0 0 avantexb http://avantexbio.com/wp-content/uploads/2017/05/avantext-bio-logo-Active-targeting-nano-particle-dual-drug-co-delivery-system-synergistic-anti-cancer-therapy-improved-cancer-therapeutics-2.png avantexb2019-03-26 08:00:462021-10-11 23:59:13Scientists Are Racing to Make Weed As Easy to Drink as Beer

Canopy Growth set to become the ‘global titan’ of cannabis: CIBC report

January 21, 2019/in In the News/by avantexb

OTTAWA CITIZEN – JACQUIE MILLER – January 21, 2019 – Canopy Growth Corp. in Smiths Falls is poised to dominate the global cannabis industry, a new report says. The CIBC World Markets report compares the cannabis industry to both the gold rush and the development of the internet and the automobile. Only a few companies will live up […]

Read more
http://avantexbio.com/wp-content/uploads/2017/05/avantext-bio-logo-Active-targeting-nano-particle-dual-drug-co-delivery-system-synergistic-anti-cancer-therapy-improved-cancer-therapeutics-2.png 0 0 avantexb http://avantexbio.com/wp-content/uploads/2017/05/avantext-bio-logo-Active-targeting-nano-particle-dual-drug-co-delivery-system-synergistic-anti-cancer-therapy-improved-cancer-therapeutics-2.png avantexb2019-01-21 12:00:292021-10-11 23:55:46Canopy Growth set to become the ‘global titan’ of cannabis: CIBC report

Popular Canadian pharmacy chain officially starts carrying medical cannabis

January 9, 2019/in In the News/by avantexb

STRAIGHT – January 9th, 2019 – Original story published by High Times.  On Tuesday, Shoppers Drug Mart started selling dried and fresh cannabis, seeds, plants, and oils Things just got more convenient for medical cannabis patients in Ontario. On Tuesday, the popular pharmacy chain Shoppers Drug Mart launched its online retail portal for medical cannabis products. Shoppers is a national […]

Read more
http://avantexbio.com/wp-content/uploads/2017/05/avantext-bio-logo-Active-targeting-nano-particle-dual-drug-co-delivery-system-synergistic-anti-cancer-therapy-improved-cancer-therapeutics-2.png 0 0 avantexb http://avantexbio.com/wp-content/uploads/2017/05/avantext-bio-logo-Active-targeting-nano-particle-dual-drug-co-delivery-system-synergistic-anti-cancer-therapy-improved-cancer-therapeutics-2.png avantexb2019-01-09 10:00:222019-01-22 06:49:28Popular Canadian pharmacy chain officially starts carrying medical cannabis

Medical marijuana pioneer Brent Zettl jumps back into business with new startup

January 8, 2019/in In the News/by avantexb

CHRISTINA PELLEGRINI CANNABIS INDUSTRY REPORTER – PUBLISHED JANUARY 7, 2019 Long before recreational cannabis, there was CanniMed Therapeutics Ltd., the first licensed producer to grow and sell medical cannabis nearly two decades ago. Now, Brent Zettl, the former head of CanniMed, is back in business with a new cannabis company. It hasn’t been that long – about […]

Read more
http://avantexbio.com/wp-content/uploads/2017/05/avantext-bio-logo-Active-targeting-nano-particle-dual-drug-co-delivery-system-synergistic-anti-cancer-therapy-improved-cancer-therapeutics-2.png 0 0 avantexb http://avantexbio.com/wp-content/uploads/2017/05/avantext-bio-logo-Active-targeting-nano-particle-dual-drug-co-delivery-system-synergistic-anti-cancer-therapy-improved-cancer-therapeutics-2.png avantexb2019-01-08 06:00:302021-10-12 00:18:42Medical marijuana pioneer Brent Zettl jumps back into business with new startup

BuyWell Introduces Canada’s first Medical Cannabis Coverage Plan and Medical Cannabis Savings Calculator

December 28, 2018/in In the News/by avantexb

REGINA LEADER POST – December 28, 2018 – Based on research and findings from Synergy Health Services, BuyWell Care consumers may realize savings of up to $5,700 per year on their medical cannabis. BuyWell.com, Canada’s first fully integrated Health and Wellness marketplace, introduces BuyWell Care: Canada’s first guaranteed issue Medical Cannabis Coverage Plan and Medical Cannabis Savings Calculator. Crop […]

Read more
http://avantexbio.com/wp-content/uploads/2017/05/avantext-bio-logo-Active-targeting-nano-particle-dual-drug-co-delivery-system-synergistic-anti-cancer-therapy-improved-cancer-therapeutics-2.png 0 0 avantexb http://avantexbio.com/wp-content/uploads/2017/05/avantext-bio-logo-Active-targeting-nano-particle-dual-drug-co-delivery-system-synergistic-anti-cancer-therapy-improved-cancer-therapeutics-2.png avantexb2018-12-28 02:00:372021-10-12 00:20:37BuyWell Introduces Canada’s first Medical Cannabis Coverage Plan and Medical Cannabis Savings Calculator

Shoppers Drug Mart Granted License to Sell Medical Cannabis Online

December 10, 2018/in In the News/by avantexb

THE CANADIAN PRESS – December 10, 2018 – Shoppers Drug Mart has been granted a license to sell medical cannabis online. Health Canada’s list of authorized cannabis producers and sellers has been updated to reflect that the pharmacy giant can fill prescriptions for dried and fresh cannabis, as well as plants, seeds, and oil. A website has been […]

Read more
http://avantexbio.com/wp-content/uploads/2017/05/avantext-bio-logo-Active-targeting-nano-particle-dual-drug-co-delivery-system-synergistic-anti-cancer-therapy-improved-cancer-therapeutics-2.png 0 0 avantexb http://avantexbio.com/wp-content/uploads/2017/05/avantext-bio-logo-Active-targeting-nano-particle-dual-drug-co-delivery-system-synergistic-anti-cancer-therapy-improved-cancer-therapeutics-2.png avantexb2018-12-10 12:00:312021-10-12 00:22:11Shoppers Drug Mart Granted License to Sell Medical Cannabis Online

Altria buys 45% stake in cannabis producer Cronos for $2.4 billion

December 7, 2018/in In the News/by avantexb

Marlboro cigarette maker Altria Group Inc said on Friday it will invest $2.4 billion in the Canadian cannabis producer Cronos Group Inc.AP Photo/Gerry Broome, File Marlboro cigarette maker Altria Group Inc made a big bet on the rapidly growing marijuana industry on Friday with a $2.4 billion investment in Canadian cannabis producer Cronos Group Inc. […]

Read more
http://avantexbio.com/wp-content/uploads/2017/05/avantext-bio-logo-Active-targeting-nano-particle-dual-drug-co-delivery-system-synergistic-anti-cancer-therapy-improved-cancer-therapeutics-2.png 0 0 avantexb http://avantexbio.com/wp-content/uploads/2017/05/avantext-bio-logo-Active-targeting-nano-particle-dual-drug-co-delivery-system-synergistic-anti-cancer-therapy-improved-cancer-therapeutics-2.png avantexb2018-12-07 12:00:262021-10-12 00:25:48Altria buys 45% stake in cannabis producer Cronos for $2.4 billion

Aphria to acquire CC Pharma, strengthening foothold in German medical cannabis market

November 8, 2018/in In the News/by avantexb

Acquisition adds new vertical and strategic operations in key region of global growth strategy. Aphria Inc. (TSX: APHA andNYSE: APHA) today announced its proposed acquisition of CC Pharma GmbH, a leading distributor of pharmaceutical products to more than 13,000 pharmacies in Germany. The transaction, when closed, will strengthen the Company’s end-to-end medical cannabis operations and infrastructure in Germany, a key market […]

Read more
http://avantexbio.com/wp-content/uploads/2017/05/avantext-bio-logo-Active-targeting-nano-particle-dual-drug-co-delivery-system-synergistic-anti-cancer-therapy-improved-cancer-therapeutics-2.png 0 0 avantexb http://avantexbio.com/wp-content/uploads/2017/05/avantext-bio-logo-Active-targeting-nano-particle-dual-drug-co-delivery-system-synergistic-anti-cancer-therapy-improved-cancer-therapeutics-2.png avantexb2018-11-08 12:00:112018-12-11 09:44:46Aphria to acquire CC Pharma, strengthening foothold in German medical cannabis market

Manulife launches Canada’s first medical marijuana program

July 31, 2018/in In the News/by avantexb

WATERLOO, Ont. — Customers will get help navigating the different strains of medical marijuana and the different ways to take it. The Manulife Financial insurance company says it will launch the first medical marijuana program in Canada this fall in conjunction with Shoppers Drug Mart. Manulife says the program will be available as an option for participating […]

Read more
http://avantexbio.com/wp-content/uploads/2017/05/avantext-bio-logo-Active-targeting-nano-particle-dual-drug-co-delivery-system-synergistic-anti-cancer-therapy-improved-cancer-therapeutics-2.png 0 0 avantexb http://avantexbio.com/wp-content/uploads/2017/05/avantext-bio-logo-Active-targeting-nano-particle-dual-drug-co-delivery-system-synergistic-anti-cancer-therapy-improved-cancer-therapeutics-2.png avantexb2018-07-31 12:00:172021-10-12 00:27:51Manulife launches Canada’s first medical marijuana program

Emblem and Canntab Therapeutics Announce Health Canada Approval for R&D of Cannabinoid-Based Oral Sustained Release Formulation

May 14, 2018/in In the News/by avantexb

PARIS, Ontario, May 14, 2018 (GLOBE NEWSWIRE) — Emblem Corp. (TSX-V:EMC) (TSX-V:EMC.WT) (“Emblem” or the “Company”) and Canntab Therapeutics Limited (CSE:PILL) (“Canntab”) are pleased to announce the receipt of Health Canada approval for research and development activities on oral sustained release formulations of cannabinoids (the “Sustained Release Product” or the “Product”), which are the proprietary […]

Read more
http://avantexbio.com/wp-content/uploads/2017/05/avantext-bio-logo-Active-targeting-nano-particle-dual-drug-co-delivery-system-synergistic-anti-cancer-therapy-improved-cancer-therapeutics-2.png 0 0 avantexb http://avantexbio.com/wp-content/uploads/2017/05/avantext-bio-logo-Active-targeting-nano-particle-dual-drug-co-delivery-system-synergistic-anti-cancer-therapy-improved-cancer-therapeutics-2.png avantexb2018-05-14 12:00:182018-12-11 08:38:15Emblem and Canntab Therapeutics Announce Health Canada Approval for R&D of Cannabinoid-Based Oral Sustained Release Formulation

Double-drug strategy blocks escape route for most lung cancers

April 3, 2018/in In the News/by avantexb

A one-two combo punch using two currently available drugs could be an effective treatment for the majority of lung cancers, a study shows. UT Southwestern Medical Center – A one-two combo punch using two currently available drugs could be an effective treatment for the majority of lung cancers, a study by scientists with UT Southwestern’s […]

Read more
http://avantexbio.com/wp-content/uploads/2017/05/avantext-bio-logo-Active-targeting-nano-particle-dual-drug-co-delivery-system-synergistic-anti-cancer-therapy-improved-cancer-therapeutics-2.png 0 0 avantexb http://avantexbio.com/wp-content/uploads/2017/05/avantext-bio-logo-Active-targeting-nano-particle-dual-drug-co-delivery-system-synergistic-anti-cancer-therapy-improved-cancer-therapeutics-2.png avantexb2018-04-03 12:00:442021-10-12 00:30:39Double-drug strategy blocks escape route for most lung cancers

Santen Pharmaceutical to Leverage Medidata Edge CTMS to Drive Future Growth in Ophthalmic Clinical Development

March 22, 2018/in In the News/by avantexb

Company adopts Edge CTMS in Japan as part of rapid global expansion February 20, 2018 08:30 AM Eastern Standard Time NEW YORK – (BUSINESS WIRE) – Santen Pharmaceutical Co., Ltd, is expanding its use of the Medidata Clinical Cloud® with the adoption of Edge CTMS (Clinical Trial Management System) to support its clinical trial operations, […]

Read more
http://avantexbio.com/wp-content/uploads/2017/05/avantext-bio-logo-Active-targeting-nano-particle-dual-drug-co-delivery-system-synergistic-anti-cancer-therapy-improved-cancer-therapeutics-2.png 0 0 avantexb http://avantexbio.com/wp-content/uploads/2017/05/avantext-bio-logo-Active-targeting-nano-particle-dual-drug-co-delivery-system-synergistic-anti-cancer-therapy-improved-cancer-therapeutics-2.png avantexb2018-03-22 12:00:242018-03-22 00:53:33Santen Pharmaceutical to Leverage Medidata Edge CTMS to Drive Future Growth in Ophthalmic Clinical Development

Dry Eye Disease Market, Punctal Plugs, and Secretagogue; Distribution Channel

March 13, 2018/in In the News/by avantexb

Hospital Pharmacies, Independent Pharmacies & Drug Stores, and Online pharmacies – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2017 – 2025 LONDON, March 13, 2018 /PRNewswire/ — Global Dry Eye Disease Market: Overview – News provided by ReportBuyer Dry eye is an ocular disease caused due to insufficiency or lack of tears in eye. […]

Read more
http://avantexbio.com/wp-content/uploads/2017/05/avantext-bio-logo-Active-targeting-nano-particle-dual-drug-co-delivery-system-synergistic-anti-cancer-therapy-improved-cancer-therapeutics-2.png 0 0 avantexb http://avantexbio.com/wp-content/uploads/2017/05/avantext-bio-logo-Active-targeting-nano-particle-dual-drug-co-delivery-system-synergistic-anti-cancer-therapy-improved-cancer-therapeutics-2.png avantexb2018-03-13 12:00:162018-03-22 00:51:05Dry Eye Disease Market, Punctal Plugs, and Secretagogue; Distribution Channel
Page 1 of 212

  • Industry News
  • Media Contact

INDUSTRY NEWS

  • What to Expect From the Launch of Cannabis Edibles in CanadaDecember 31, 2019 - 12:00 pm
  • New Cannabis Products to Follow Edibles LegalizationSeptember 5, 2019 - 12:00 pm
  • Canada’s cannabis edibles, topicals market could be worth $2.7B a year after legalization: studyJune 3, 2019 - 12:00 pm
  • Scientists Are Racing to Make Weed As Easy to Drink as BeerMarch 26, 2019 - 8:00 am
  • Canopy Growth set to become the ‘global titan’ of cannabis: CIBC reportJanuary 21, 2019 - 12:00 pm
  • Popular Canadian pharmacy chain officially starts carrying medical cannabisJanuary 9, 2019 - 10:00 am

ABOUT
Overview
Management & Directors
Disclaimer

BIOTECH APPLICATIONS
Eye-Care Application
Lung Cancer Application
– Lung Cancer Problem
– Lung Cancer in China
Cannabis Applications
MRI Application
Research Papers

NEWS
Industry News
Media Contact

CONTACT
Contact Information

CONTACT
Nikita Chou, President
E: nchou@avantexbio.com
M: +1-778-888-3892

Ullrich Schade, VP Marketing
E: uschade@avantexbio.com
M: +1-604-644-4914

Branding by:
NextPhase Strategy

Scroll to top